Gritstone to Host Data Update on CORAL and Discuss the Application of Self-amplifying mRNA ...
bdtonline.com
news
2022-10-19 11:03:14

-- Data to be presented from CORAL-BOOST and CORAL-CEPI trials evaluating Gritstone's samRNA vaccine candidates against SARS-CoV-2 --EMERYVILLE, Calif., Oct. 19, 2022 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company that aims to develop the world's most potent vaccines, today announced that it will host a webinar on October 25, 2022 to present data from its CORAL program and discuss the application of its self-amplifying mRNA (samRNA) vaccine platform for infectious diseases.
